Statins × lipids

TrialCardiovascular diabetology2010

Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study).

Gianluca Bardini et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 93 people · 2010

No range given

Reported higher lipids, no range given

2.8×

Bigger than 9 in 10 on the map

As reported

OR 2.81, no interval

One number in the abstract

the abstract, start to end

significant (78.4% vs 60%; odds ratio = 2.81; p = 0.052).

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Lipids
OR 2.81
StatinsLipids
1 / 3

16 papers cite it

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 20492655